share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144：擬議出售證券
美股sec公告 ·  03/29 00:45
牛牛AI助理已提取核心訊息
Christopher Gibson, an officer and director at Recursion Pharmaceuticals, Inc., is set to sell 65,000 Class A shares of the company on 03/28/2024, with an aggregate market value of $656,500. The shares to be sold were acquired through various transactions dating back to September 1, 2016, including founders shares, stock option exercises, and restricted stock vesting. The most recent acquisition was on May 15, 2023, when Gibson received 1,507 shares as compensation. This planned sale follows a series of transactions over the past three months, where a total of 165,444 shares were sold for gross proceeds of approximately $1.69 million. The notice for the upcoming sale was filed on the same date as the planned sale, with the sale plan having been adopted on December 27, 2023.
Christopher Gibson, an officer and director at Recursion Pharmaceuticals, Inc., is set to sell 65,000 Class A shares of the company on 03/28/2024, with an aggregate market value of $656,500. The shares to be sold were acquired through various transactions dating back to September 1, 2016, including founders shares, stock option exercises, and restricted stock vesting. The most recent acquisition was on May 15, 2023, when Gibson received 1,507 shares as compensation. This planned sale follows a series of transactions over the past three months, where a total of 165,444 shares were sold for gross proceeds of approximately $1.69 million. The notice for the upcoming sale was filed on the same date as the planned sale, with the sale plan having been adopted on December 27, 2023.
Recursion Pharmicals, Inc. 的高管兼董事克里斯托弗·吉布森定於2024年3月28日出售該公司的65,000股A類股票，總市值爲656,500美元。待售股票是通過可追溯到2016年9月1日的各種交易收購的，包括創始人股票、股票期權行使和限制性股票歸屬。最近一次收購是在2023年5月15日，當時吉布森獲得了1,507股股票作爲薪酬。此次計劃出售是在過去三個月進行的一系列交易之後進行的，共出售了165,444股股票，總收益約爲169萬美元。即將進行的出售通知與計劃出售的同一天提交，銷售計劃已於2023年12月27日通過。
Recursion Pharmicals, Inc. 的高管兼董事克里斯托弗·吉布森定於2024年3月28日出售該公司的65,000股A類股票，總市值爲656,500美元。待售股票是通過可追溯到2016年9月1日的各種交易收購的，包括創始人股票、股票期權行使和限制性股票歸屬。最近一次收購是在2023年5月15日，當時吉布森獲得了1,507股股票作爲薪酬。此次計劃出售是在過去三個月進行的一系列交易之後進行的，共出售了165,444股股票，總收益約爲169萬美元。即將進行的出售通知與計劃出售的同一天提交，銷售計劃已於2023年12月27日通過。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。